FSD Pharma
is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of brain and inflammatory disorders... Read moreFSD Pharma
is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of brain and inflammatory disorders... Read more
News
Oct 29, 2024
Newswire
Press Release: FSD Pharma : Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Oct 22, 2024
Accesswire
Press Release: FSD Pharma : Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Aug 23, 2024
FinanzNachrichten
FSD Pharma: Quantum Biopharma Ltd.: Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
Aug 15, 2024
iNVEZZ
FSD Pharma: FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"
Aug 14, 2024
Marketscreener
FSD Pharma: FSD Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Aug 12, 2024
Marketscreener
FSD Pharma: FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd Stick Packs this Month Created by a World-Class Pharmaceutical Research and Development Team
Jul 23, 2024
MarketScreener
FSD Pharma: 24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
Jul 04, 2024
MarketScreener
FSD Pharma: FSD Pharma Files Amended and Restated Material Change Report
Jun 29, 2024
Pharmabiz
FSD Pharma: FSD Pharma receives HERC approval for a phase1 multiple ascending doses clinical trial for Lucid21302 in Australia
Jun 28, 2024
FinanzNachrichten
FSD Pharma: FSD Pharma Inc.: FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
FSD Pharma Competitors
1
2
3
4
5
6